Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA036141 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA036141, RRID:AB_10672079
- Product name
- Anti-MGEA5
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human MGEA5, Gene description: meningioma expressed antigen 5 (hyaluronidase), Alternative Gene Names: MEA5, NCOAT, OGA, Validated applications: IHC, WB, Uniprot ID: O60502, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Neurodevelopmental defects in a mouse model of O-GlcNAc transferase intellectual disability
Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation
Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis
Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Authier F, Ondruskova N, Ferenbach A, McNeilly A, van Aalten D
Disease Models & Mechanisms 2024;17(4)
Disease Models & Mechanisms 2024;17(4)
Enzymatic assay for UDP-GlcNAc and its application in the parallel assessment of substrate availability and protein O-GlcNAcylation
Sunden M, Upadhyay D, Banerjee R, Sipari N, Fellman V, Kallijärvi J, Purhonen J
Cell Reports Methods 2023;3(7):100518
Cell Reports Methods 2023;3(7):100518
Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis
Muha V, Authier F, Szoke-Kovacs Z, Johnson S, Gallagher J, McNeilly A, McCrimmon R, Teboul L, van Aalten D
Journal of Biological Chemistry 2021;296
Journal of Biological Chemistry 2021;296
Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells
Weiss M, Anderluh M, Gobec M
Cells 2021;10(12):3312
Cells 2021;10(12):3312
Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9
Itkonen H, Poulose N, Steele R, Martin S, Levine Z, Duveau D, Carelli R, Singh R, Urbanucci A, Loda M, Thomas C, Mills I, Walker S
Molecular Cancer Research 2020;18(10):1512-1521
Molecular Cancer Research 2020;18(10):1512-1521
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells
Itkonen H, Urbanucci A, Martin S, Khan A, Mathelier A, Thiede B, Walker S, Mills I
Theranostics 2019;9(8):2183-2197
Theranostics 2019;9(8):2183-2197
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism
Itkonen H, Gorad S, Duveau D, Martin S, Barkovskaya A, Bathen T, Moestue S, Mills I
Oncotarget 2016;7(11):12464-12476
Oncotarget 2016;7(11):12464-12476
No comments: Submit comment
No validations: Submit validation data